Selvakumar Anbalagan
London, ENG SM25NG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Transcriptomic Profiling of the Immune Response in Orthotopic Pancreatic Tumours Exposed to Combined Boiling Histotripsy and Oncolytic Reovirus Treatment.
Journal: Pharmaceutics
Published: May 29, 2025
Modulating Redox Biology to Improve Radiation Responses.
Journal: Cancer journal (Sudbury, Mass.)
Published: April 15, 2025
Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: November 03, 2023
Applicability of Scoring Calyculin A-Induced Premature Chromosome Condensation Objects for Dose Assessment Including for Radiotherapy Patients.
Journal: Cytogenetic and genome research
Published: March 22, 2023
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 23, 2021
An ionising radiation-induced specific transcriptional signature of inflammation-associated genes in whole blood from radiotherapy patients: a pilot study.
Journal: Radiation oncology (London, England)
Published: January 21, 2021
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.
Journal: Scientific reports
Published: December 18, 2020
Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: March 24, 2020
Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity.
Journal: Molecular cancer therapeutics
Published: January 03, 2017
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
Journal: Nature communications
Published: December 04, 2015
Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1.
Journal: Scientific reports
Published: October 13, 2015
Last Updated: 09/26/2026